The majority of caregivers preferred the kinesthetic learning method, whether as a single learning preference or in combination with other approaches. Incorporating kinesthetic methods of learning, such as role plays and problem-solving case scenarios, into standardized asthma education curricula may be beneficial to patients and families in terms of understanding and using their regimen.
Objective: To determine the factors associated with the high medication regimen complexity in pediatric patients with chronic kidney disease. Methods: An observational, cross-sectional, descriptive and analytical study was conducted with patients treated at a multiprofessional outpatient clinic of a public teaching hospital. Data were collected from July to September 2019 from the medical record and pharmacotherapeutic follow-up form. The medication regimen complexity was the dependent variable and was assessed by the Medication Regimen Complexity Index. The independent variables were sex, age, number of diseases, number of medications, adherence to treatment and access to health services. The complexity was considered high when the the Medication Regimen Complexity Index was greater than 13.5 points. The association between the occurrence of high complexity of pharmacotherapy and the independent variables was performed using Pearson’s chi-square test and Fisher’s exact test. For univariate and multivariate analysis, the magnitude of the association was expressed by the odds ratio with a 95% confidence interval. Results: All patients treated during the study period were included in the study (n = 31). 67.7% of patients (n = 21) used at least four drugs, the same percentage presented complexity of high pharmacotherapy, being associated with the number of drugs used (p <0.001). The class of drugs, plus drugs that do not act on the cardiovascular system, 30% (n = 30). The most used medication by patients was sodium bicarbonate (n = 22; 70%). Conclusions: The high medication regimen complexity was associated with the number of drugs used and was observed in most patients studied, highlighting the importance of assessing the ICFT in children to optimize pharmacotherapy and, consequently, pediatric patient safety.
Objective: To describe the identification of drugs with similar primary packaging available in a large teaching hospital. Methods: This is a descriptive study carried out using a multi-step approach. First, the small volume parenteral drugs and oral solutions available at the institution (Step I) were listed. Then, from the list developed in Step I, groups of drugs with similar packaging (double, trio or foursome) were identified according to their characteristics (Step II). These groups were then visually evaluated by the pharmacy team (Step III), and later by the internal community of the institution (Step IV). Results: A total of 233 drugs in the pharmaceutical forms of interest were available at the institution (Stage I). In step II, 62 groups with similar primary packaging were identified. After evaluation by the pharmacy team, 19 groups remained (Stage III), which were then evaluated by the internal community, generating a final list of 15 groups of drugs with similar primary packaging. Among these, the pharmaceutical form of parenteral use (80%) and the amber ampoule as primary packaging (46.7%) were frequent. Conclusion: The results of the study point to the applicability and adequacy of the multistep approach to identify the presence of groups of drugs with similar primary packaging in a real-world scenario. The identification of these groups of drugs in health care institutions is the first important step to plan strategies to minimize errors involving similar packaging, thus increasing the safety of medication use in the hospital environment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.